The largest database of trusted experimental protocols

4 protocols using c2821

1

Immunofluorescent Analysis of TEVG Neotissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Frozen TEVGs were sectioned using a cryo-microtome at an 8 μm thickness prior to being mounted on gelatin coated slides and stained using standard indirect immunofluorescent chemistry. Primary antibodies utilized were as follows: von Willebrand Factor (vWF) [1:250; US Biological #V2700-07], smooth muscle alpha-actin (SMA) [1:1000; Sigma #A5228], calponin [1:250; Abcam #ab46794], and elastin [1:100; EPC #RA75]. The following secondary antibodies were utilized: [Rockland #611-1202 (1:1000)], [Invitrogen #A10521 (1:1000)], [Sigma #C2821 (1:300)]. Explants were also stained with H&E. All images were taken using a 20x objective with an epifluorescent microscope utilizing NIS Elements software. Analysis was restricted to the newly developed luminal tissue within TEVGs (termed as “neotissue”).
+ Open protocol
+ Expand
2

Quantifying ANO1 Expression in Myotubes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six days old cultured normal myotubes were washed with 1x PBS, fixed in 4% paraformaldehyde both supplemented with 100 µM N-benzyl-p-toluene sulphonamide (BTS) and blocked by incubating in 5% goat or rabbit serum, as described in detail34 (link). Primary and secondary antibodies, diluted in PBS supplemented with 0.2% BSA and Triton X-100 were as follows: mouse monoclonal antibody 1A against DHPRα1S (1:2,000, MA3-920, Affinity Bioreagents), rabbit polyclonal anti-ANO1 (1:50, ab84115, Abcam), goat polyclonal anti-ANO5 (1:500, sc-169628, Santa Cruz), rabbit anti-GFP (1:5,000, A11122, Invitrogen), secondary goat anti-mouse Alexa Fluor 594, goat anti-rabbit Alexa Fluor 488 (both 1:4,000, A11032 and A11034, respectively, Invitrogen), rabbit anti-goat Cy3 and rabbit anti-mouse FITC (1:500, C2821, and 1:2,000, F9137, respectively, Sigma).
Images were recorded with a cooled CCD camera (Diagnostic Instruments) and MetaVue image processing software (v 6.2, Universal Imaging, PA). Quantification of ANO1 surface membrane expression after siRNA knock-down was determined by measuring the average fluorescence intensity along the periphery of CFP positive myotubes, obtained from at least two different cultures using the MetaVue software.
+ Open protocol
+ Expand
3

Immunohistochemical Analysis of Desmin in Cardiac Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Explanted septal, left-, and right–ventricular myocardial tissue was fixed in 4% Roti Histofix (Carl Roth, Karlsruhe, Germany) and was embedded in paraffin. We prepared 5 µm sections using a microtome (Leica, Wetzlar, Germany) that were deparaffinized using xylene and ethanol as described [25 (link)]. Bovine serum albumin (5% in phosphate buffered saline, PBS) was used for blocking (30 min, room temperature). Polyclonal goat anti-desmin antibodies (15 µg/mL, #AF3844, R&D Systems, Minneapolis, MN, USA) were used in combination with secondary anti-goat antibodies conjugated to Cy3 (1:100, #C2821, Sigma-Aldrich, St. Louis, MO, USA) for desmin labelling. We used 4′,6-diamidino-2-phenylindole (DAPI, 1 µg/mL) for nuclei staining (5 min, RT). Myocardial tissue was embedded using Fluorescent Mounting Medium (Dako, Glostrup, Denmark). Confocal microscopy was performed as previously described [26 (link)].
+ Open protocol
+ Expand
4

Multiparametric Immunostaining of AIF, Caspase-3 and GDNF

Check if the same lab product or an alternative is used in the 5 most similar protocols
A sequential immunostaining protocol was performed to study the expression of AIF (1:200, SC-9416, Santa Cruz Biotechnology Inc, USA) and caspase-3 (1:200, SC-7148, Santa Cruz Biotechnology Inc, USA) as well as GDNF (1:200, SC-328, Santa Cruz Biotechnology Inc, USA) co-labelling with TH (Vidyadhara et al., 2017 , Alladi, et al., 2010a) . Briefly, the sections were equilibrated (0.1M PBS, pH 7.4) and blocked for 1h in 3% BSA. Thereafter, the sections were incubated with the primary antibody (48 hr at 4°C). This was followed by incubation with appropriate secondary antibodies i.e. Cy3-conjugated (1:200; C2821 or C2181; Sigma Aldrich, USA), FITC-conjugated (1:200; F7367 or F7512, Sigma Aldrich, USA) or Cy5-conjugated secondary antibodies (1:200; AP192SA6; Merck Millipore, USA; 17 hrs at 4°C). Similar immunolabeling steps were followed for the subsequent sequential staining. We used 0.01 M PBST (pH 7.4) as both working and washing buffer. Negative controls sections were incubated with only dilution buffer. Sections were mounted using Vectashield hard set mounting medium (H-400; Vector Laboratories, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!